Live Breaking News & Updates on Genfit Company Profile

Stay updated with breaking news from Genfit company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Boosts Genfit (NASDAQ:GNFT) Price Target to $11.00

Genfit (NASDAQ:GNFT – Free Report) had its target price increased by HC Wainwright from $9.00 to $11.00 in a research note issued to investors on Monday morning, FlyOnTheWall reports. A number of other research firms have also weighed in on GNFT. SVB Leerink reaffirmed an outperform rating on shares of Genfit in a research note […] ....

United States , Optiver Holding , Genfit Company Profile , Shaughnessy Asset Management , Envestnet Asset Management Inc , Citadel Advisors , Free Report , Asset Management , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily , Nasdaq Gnft , Boost Price Target , Hc Wainwright ,

Genfit (GNFTF) & The Competition Financial Comparison

Genfit (OTCMKTS:GNFTF – Free Report) is one of 370 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Genfit to related businesses based on the strength of its earnings, valuation, risk, dividends, profitability, institutional ownership and analyst recommendations. Insider and Institutional Ownership 11.1% of Genfit shares are […] ....

Genoscience Pharma , Genfit Company Profile , Free Report , Given Genfit , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily ,

Genfit (GNFTF) and Its Rivals Head-To-Head Comparison

Genfit (OTCMKTS:GNFTF – Free Report) is one of 400 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Genfit to similar companies based on the strength of its valuation, institutional ownership, earnings, dividends, profitability, analyst recommendations and risk. Institutional and Insider Ownership 11.1% of Genfit shares are […] ....

Genoscience Pharma , Genfit Company Profile , Free Report , Given Genfit , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily ,

Genfit S.A. (NASDAQ:GNFT) Sees Significant Increase in Short Interest

Genfit S.A. (NASDAQ:GNFT – Get Rating) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 101,300 shares, a growth of 5.4% from the May 15th total of 96,100 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 14.3 days. Currently, […] ....

United States , Envestnet Asset Management Inc , Shaughnessy Asset Management , Optiver Holding , Genfit Company Profile , Citadel Advisors , Get Rating , Asset Management , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily ,

Analyzing Genfit (GNFTF) and Its Peers

Genfit (OTCMKTS:GNFTF – Get Rating) is one of 346 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genfit to similar companies based on the strength of its profitability, analyst recommendations, earnings, valuation, institutional ownership, dividends and risk. Valuation and Earnings This table compares Genfit […] ....

Bart Staels , Genfit Company Profile , Get Rating , Given Genfit , Genfit Daily ,